Paragon 28

Paragon 28 ROCE

Delisted

The Return on Capital Employed (ROCE) of Paragon 28 (FNA) as of Nov 3, 2026 is -32.12 %. In the previous year, Return on Capital Employed (ROCE) was -24.33 % — a change of 32.06% (lower).

ROCE

-32.12 %

YoY

32.06%

Last updated:

In 2024, Paragon 28's return on capital employed (ROCE) was -32.12 %, a 32.06% increase from the -24.33 % ROCE in the previous year.

The Paragon 28 ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2019
9.97 USD
Jan 1, 2020
7.87 USD
Jan 1, 2021
-5.86 USD
Jan 1, 2022
-43.70 USD
Jan 1, 2023
-24.33 USD
Jan 1, 2024
-32.12 USD
The Paragon 28 ROCE history
YEARROCEYoY
-32.12 %+32.06%
-24.33 %-44.33%
-43.70 %+645.82%
-5.86 %-174.43%
7.87 %-21.03%
9.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Paragon 28 Stock analysis

What does Paragon 28 do? Paragon 28, Inc. generates revenue through the development, distribution, and sale of medical devices in the foot and ankle orthopedic implant market. The company offers a comprehensive portfolio including plates and plating systems, screws, staples, and nails for fracture fixation, bunion and hammertoe procedures, ankle treatments, flatfoot correction, and Charcot foot solutions. Its surgical solutions consist of 75 product systems with approximately 9,200 SKUs, comprising 6,800 implants, 1,400 instruments, and 1,000 disposables. Hospitals and orthopedic surgeons purchase these products for patient care and surgical procedures. The company’s product families address all foot and ankle procedures, including progressive collapsing foot deformity (PCDF) and orthobiologics. Surgical implants, disposables, and instrumentation are sold directly to healthcare providers. The firm’s focus on specialized foot and ankle solutions allows it to serve a niche segment within the orthopedic implant marketplace. Paragon 28’s portfolio includes approximately 6,800 implants, 1,400 instruments, and 1,000 disposable SKUs, providing tailored options for diverse surgical needs. Paragon 28, Inc. operates within the orthopedic implant industry, targeting hospitals and surgical centers specializing in foot and ankle care. Its products are designed for specific anatomical and surgical requirements, with sizes and configurations varying to fit individual patient needs. The company’s revenue is derived from the sale of its extensive product range, including surgical implants, disposables, and instrumentation, to healthcare providers who perform foot and ankle procedures. Paragon 28 is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Paragon 28's Return on Capital Employed (ROCE)

Paragon 28's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Paragon 28's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Paragon 28's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Paragon 28’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Paragon 28 stock

Return on Capital Employed (ROCE) of Paragon 28 is -32.12 % in 2024.

Return on Capital Employed (ROCE) of Paragon 28 changed from -24.33 % to -32.12 %, representing a 32.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Paragon 28 since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Paragon 28 with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Paragon 28

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Paragon 28